| Page 935 | Kisaco Research

Andrew Buchanan

When you have well curated data the potential is great. Exploring and validation the potential for prediction functional PD effects. Ultimately using clinical data and insights to design better molecules faster.

Gian Marco Ghiandoni

I am excited about being able to share some content on how AstraZeneca uses AI/ML to boost productivity and deliver business value. I am as well looking forward to hearing from other people working in my field and possibly coming home with some ideas for my projects.

 

Francesca Hodges

Knowledge Transfer Manager
Innovate UK

Francesca Hodges

Knowledge Transfer Manager
Innovate UK

Francesca Hodges

Knowledge Transfer Manager
Innovate UK

Emilie Louvet

AI is used along the drug discovery and development pipeline: from target discovery, drug design up to commercialization.  Clinical science benefits from AI upon multiple aspects to enable trials design in a faster and more optimal way.

 

Riko Kimoto

Senior Project Manager
Asia-Europe Foundation

Riko KIMOTO leads the thematic area of Public Health, which covers AMR, from conceptualisation to implementation at Asia-Europe Foundation (ASEF), an intergovernmental not-for-profit organisation located in Singapore. Prior to joining ASEF, she gained field experience in other continents, including Latin America and Africa. Riko has a Bachelor of Nursing degree from Australian Catholic University, and she is a qualified nurse with several years of clinical experience. She then obtained her Master’s degree in International Public Health (MIPH) from the University of Queensland.

Riko Kimoto

Senior Project Manager
Asia-Europe Foundation

Riko Kimoto

Senior Project Manager
Asia-Europe Foundation

Riko KIMOTO leads the thematic area of Public Health, which covers AMR, from conceptualisation to implementation at Asia-Europe Foundation (ASEF), an intergovernmental not-for-profit organisation located in Singapore. Prior to joining ASEF, she gained field experience in other continents, including Latin America and Africa. Riko has a Bachelor of Nursing degree from Australian Catholic University, and she is a qualified nurse with several years of clinical experience. She then obtained her Master’s degree in International Public Health (MIPH) from the University of Queensland.

 

Julian Parkhill

Professor
University of Cambridge

Julian is currently a professor in the Department of Veterinary Medicine at the University of Cambridge. His research interests are focussed on the evolution of bacterial pathogens, and his group uses large-scale genomics to understand their origin and transmission, and how they adapt to selective pressures such as antibiotics and vaccines. Over the last few years his group has identified the global origin and routes of spread of many human and animal pathogens, and discovered mechanisms of resistance to antibiotics and evasion of vaccines.

Julian Parkhill

Professor
University of Cambridge

Julian Parkhill

Professor
University of Cambridge

Julian is currently a professor in the Department of Veterinary Medicine at the University of Cambridge. His research interests are focussed on the evolution of bacterial pathogens, and his group uses large-scale genomics to understand their origin and transmission, and how they adapt to selective pressures such as antibiotics and vaccines. Over the last few years his group has identified the global origin and routes of spread of many human and animal pathogens, and discovered mechanisms of resistance to antibiotics and evasion of vaccines. Before moving to Cambridge in 2019, he worked at the Wellcome Sanger Institute for 20 years. He was elected to the Academy of Medical Science in 2009, the American Academy of Microbiology in 2012, and as a Fellow of the Royal Society in 2014.

 

Fatema Rafiqi

Research Program Manager
Access to Medicine Foundation

Fatema Rafiqi

Research Program Manager
Access to Medicine Foundation

Fatema Rafiqi

Research Program Manager
Access to Medicine Foundation
 

Diana Nasike

Health Security Policy Officer
Ministry of Public Health Uganda

Diana Nasike

Health Security Policy Officer
Ministry of Public Health Uganda

Diana Nasike

Health Security Policy Officer
Ministry of Public Health Uganda
 

David Findlay

CEO
Rostra Therapeutics

David Findlay

CEO
Rostra Therapeutics

David Findlay

CEO
Rostra Therapeutics
 

Jason Clark

CSO
Fixed Phage

Jason Clark

CSO
Fixed Phage

Jason Clark

CSO
Fixed Phage